Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum

Journal of Comparative Neurology

Volumn 374, Issue 1, 1996, Pages 70-83

  Hiroi, Noboru ^a,b   Graybiel, Ann M ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

extrapyramidal side effects; Fos; FosB; neuroleptics; striosome

Indexed keywords

CLOZAPINE; ENKEPHALIN; HALOPERIDOL; METOCLOPRAMIDE; NEUROLEPTIC AGENT; PHOSPHOPROTEIN DARPP 32; PROTEIN C FOS; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; EXTRAPYRAMIDAL SYSTEM; IMMUNOHISTOCHEMISTRY; MALE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; TRANSCRIPTION REGULATION;

ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; CORPUS STRIATUM; HALOPERIDOL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; METOCLOPRAMIDE; NEURONS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION FACTORS;

EID: 0029796037     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9861(19961007)374:1<70::AID-CNE5>3.0.CO;2-K     Document Type: Article

References (83)

1. Ackenheil, M., H. Beau, A. Burkhart, A. Franke, and W. Packa (1976) Anti-psychotishe Wirksamkeit im Verhaltnis zum plasmaspiegel von Clozapine. Arzneimittel forschung 26:1156-1158.
2. Anden, N.E. (1972) Dopamine turnover in the corpus striatum and the limbic system after treatment with neuroleptic and anti-acetylcholine drugs. J. Pharm. Pharmacol. 24:905-906.
3. Anderson, K.D., and A. Reiner (1991) Immunohistochemical localization of DARPP-32 in striatal projection neurons and striatal interneurons: implication for the localization of D1-like dopamine receptors on different types of striatal neurons. Brain Res. 568:235-243.
4. Angst, J., D. Bente, P. Berner, H. Heimann, H. Helmchen, and H. Hippius (1971) Das klinische irkungsbild von Clozapin. Pharmakopsychiatry 4:201-211.
5. Angulo, J.A., and B.S. McEwen (1994) Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res. Rev. 19:1-28.
6. Baldessarini, R., and D. Tarsy (1980) Dopamine and the pathophysiology of dyskinesias induced by anti-psychotic drugs. Annu. Rev. Neurosci. 3:23-41.
7. Bernard, V., B. Dumartin, E. Lamy, and B. Bloch (1993) Fos immunoreactivity after stimulation or inhibition of muscarinic receptors indicates anatomical specificity for cholinergic control of striatal efferent neurons and cortical neurons in the rat. Eur. J. Neurosci. 5:1218-1225.
8. Berretta, S., H.A. Robertson, and A.M. Graybiel (1992) Dopamine and glutamate agonists stimulate neuron-specific transcriptional activation of c-fos in the striatum J. Neurophysiol. 65:767-777.
9. Berridge, M. (1986) Second messenger dualism in neuromodulation and memory. Nature 323:294-295.
10. Bissette, G., and C.B. Nemeroff (1985) Do neuropeptide systems mediate some of the effects of antipsychotic drugs? Prog. Clin. Biol. Res. 192:349-353.
11. Bogerts, B., J.A. Lieberman, M. Ashtari, R.M. Bilder, G. Degreef, G. Lerner, C. Johns, and S. Masiar (1993) Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia. Biol. Psychiatry 33:236-246.
12. Braude, W., T. Barnes, and S. Gore (1983) Clinical characteristics of akathisia: a systematic investigation of acute psychiatric inpatient admissions. Br. J. Psychiatry 143:139-150.
13. Bronstein, D.M., H. Ye, K.R. Pennypacker, P.M. Hudson, and J.-S. Hong (1994) Role of a 35 kDa fos-related antigen (FRA) in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine-lesioned rats. Mol. Brain Res. 23:191-203.
14. Carlsson, A. (1988) The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1:179-203.
15. Casey, D.E. (1989) Clozapine: neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacology (Berl.) 99:47-53.
16. Chen, J.-S., H.E. Nye, M.B. Kelz, N. Hiroi, Y. Nakabeppu, B.T. Hope, and E.J. Nestler (1995) Regulation of Δ FosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments. Mol. Pharmacol. 48: 880-889.
17. Chouinard, G., and L. Annable (1976) Clozapine in the treatment of newly admitted schizophrenic patients. A pilot study. J. Clin. Pharm. Ther. 16:289-297.
18. Chiodo, L.A., and B.S. Bunney (1983) Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J. Neurosci. 3:1607-1619.
19. Civelli, O., J. Douglass, A. Goldstein, and E. Herbert (1985) Sequence and expression of the rat prodynorphin gene. Proc. Natl. Acad. Sci. U.S.A. 82:4291-4295.
20. Cleghorn, J.L., R.B. Zipursky, and S.J. List (1991) Structural and functional brain imaging in schizophrenia. J. Psychiatry Neurosci. 16:53-74.
21. Comb, M., S.E. Hyman, and H.M. Goodman (1987) Mechanisms of transsynaptic regulation of gene expression. Trends Neurosci. 10:473-478.
22. Deutch, A.Y., M.C. Lee, and M.J. Iadarola (1992) Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: the nucleus accumbens shell as a locus of antipsychotic action. Mol. Cell. Neurosci. 3:332-341.
23. Dilts, R.P., Jr., T.E. Helton, and J.F. McGinty (1993) Selective induction of Fos and FRA immunoreactivity within the mesolimbic and mesostriatal dopamine terminal fields. Synapse 13:251-263.
24. Dragunow, M. (1990) Presence and induction of FosB-like immunoreactivity in neural, but not non-neural, cells in adult rat brain. Brain Res. 533:324-328.
25. Ellenbroek, B.A. (1993) Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs. Pharmacol. Ther. 57:1-78.
26. Ellenbroek, B.A., M. Schwarz, K.-H. Sontag, R. Jaspers, and A. Cools (1985) Muscular rigidity and delineation of a dopamine-sensitive neostriatal subregion: tonic EMG activity in rats. Brain Res. 345:132-140.
27. Gerfen, C.R. (1992) The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 15:133-138.
28. Gerfen, C.R., and W.S. Young III (1989) Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460:161-167.
29. Goelet, P., V.F. Castelluci, S. Schacher, and E.R. Kandel (1986) The long and the short of long-term memory - a molecular framework. Nature 322: 419-422.
30. Graybiel, A.M. (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13:244-254.
31. Gross, H., and E. Langner (1966) The active profile of a novel broad-spectrum neuroleptic of the benzodiazepine group. Wien Med. Wochenschr. 40:814-816.
32. Harvey, P.D., M. Davidson, P. Powchik, J. Schmeidler, R. McQueeney, R. Kaminsky, and K.L. Davis (1991) The course and clinical predictors of treatment response in schizophrenia. Schizophr. Res. 5:161-166.
33. Hippius, H. (1989) The history of clozapine. Psychopharmacology (Berl.) [Suppl.] 99:S3-S5.
34. Hiroi, N., and A.M. Graybiel (1992) Effects of chronic clozapine treatment on induction of Fos-like proteins in the striatum. Soc. Neurosci. Abstr. 18:1043.
35. Hiroi, N., and A.M. Graybiel (1993a) Typical and atypical neuroleptics stimulate contrasting patterns of neuropeptides and FOS/FRA expression in the striatum. Soc. Neurosci. Abstr. 19:129.
36. Hiroi, N., and A.M. Graybiel (1993b) Atypical and typical neuroleptics differentially activate Fos family members in striatal neurons. Eur. J. Neurosci. [Suppl.] 6:263.
37. Hiroi, N., H.A. Robertson, and A.M. Graybiel (1991) Fos is induced by the antipsychotic drug clozapine in the rat striatum. Soc. Neurosci. Abstr. 17:685.
38. Hope, B.T., G.J. Michael, K.M. Knigge, and S.R. Vincent (1991) Neuronal NADPH diaphorase is a nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A. 88:2811-2814.
39. Hope, B., M.B. Kelz, R.S. Duman, and E.J. Nestler (1994a) Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics. J. Neurosci. 14:4318-4328.
40. Hope, B., H.E. Nye, M.B. Kelz, D.W. Self, M.J. Iadarola, Y. Nakabeppu, R.S. Duman, and E.J. Nestler (1994b) Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 13:1235-1244.
41. Hughes, P., and M. Dragunow (1995) Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol. Rev. 47:133-178.
42. Hyman, S.E., and E.J. Nestler (1993) The Molecular Foundations of Psychiatry. Washington, DC: American Psychiatric Press.
43. Iadarola, M.J., C.L. Yeung, G. Draisci, and M.A. Ruda (1989) Prolonged elevation of multiple Fos immunoreactive proteins in rat spinal cord: western blot and immunocytochemical analysis. Soc. Neurosci. Abstr. 15:468.
44. Johansson, B., K. Lindstrom, and B.B. Fredholm (1994) Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine, and caffeine in the rat. Neuroscience 59:837-849.
45. Kalivas, P.W., L. Churchill, and M.A. Klitenick (1993) GABA and enkephalin projects from the nucleus accumbens and ventral pallidum to the ventral tegmental area. Neuroscience 57:1047-1060.
46. Kane, J.M., G. Honigfeld, J. Singer, H. Meltzer, and Clozaril Collaborative Study Group (1988) Clozapine for the treatment-resistant schizophrenic. Arch. Gen. Psychiatry 45:789-796.
47. Kelley, A.E., and V.B. Domesick (1982) The distribution of the projection from the hippocampal formation to the nucleus accumbens in the rat: an anterograde- and retrograde-horseradish peroxidase study. Neuroscience 7:2321-2335.
48. Kislauskis, E., and P.R. Dobner (1990) Mutually dependent response elements in the cis-regulatory region of the neurotensin/neuromedin N gene integrate environmental stimuli in PC12 cells. Neuron 4:783-795.
49. Kubota, Y., S. Mikawa, and Y. Kawaguchi (1993) Neostriatal GABAergic interneurones contain NOS, calretinin or parvalbumin. Neuroreport 5:205-208.
50. Lavy, S., E. Melamed, and S. Penchas (1978) Tardive dyskinesia associated with metoclopramide. BMJ i(6105):77-78.
51. LeMoine, C., E. Normand, and B. Bloch (1991) Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc. Natl. Acad. Sci. U.S.A. 88:4205-4209.
52. MacGibbon, G.A., P.A. Lawlor, R. Bravo, and M. Dragunow (1994) Clozapine and haloperidol produce a differential pattern of immediate-early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Mol. Brain Res. 23:21-32.
53. Merchant, K.M., and D.M. Dorsa (1993) Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics. Proc. Natl. Acad. Sci. U.S.A. 90:3447-3451.
54. Monstein, H.J. (1993) Identification of an AP-1 transcription factor binding site within the human cholecystokinin (CCK) promoter. Neuroreport 4:195-197.
55. Moratalla, R., E.A. Vickers, H.A. Robertson, B.H. Cochran, and A.M. Graybiel (1993) Coordinate expression of c-fos and junB is induced in the rat striatum by cocaine. J. Neurosci. 13:423-433.
56. Moratalla, R., B. Elibol, M. Vallejo, and A.M. Graybiel (1996) Network-level changes in inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron 17:147-156.
57. Morgan, J.I., and T. Curran (1991) Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu. Rev. Neurosci. 14:421-451.
58. Mumberg, D., F.C. Lucibello, M. Schuermann, and R. Muller (1991) Alternative splicing of fosB transcripts results in differentially expressed mRNAs encoding functionally antagonistic proteins. Genes Dev. 5:1212-1223.
59. Nakabeppu, Y., and D. Nathans (1991) A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity. Cell 64:751-759.
60. Naranjo, J.R., B. Mellstrom, M. Achaval, and P. Sassone-Corsi (1991) Molecular pathway of pain: fos/jun-mediated activation of a noncanonical AP-1 site in the prodynorphin gene. Neuron 6:607-617.
61. Nguyen, T.V., B.E. Kosofsky, R. Birnbaum, B.M. Cohen, and S.E. Hyman (1992) Differential expression of c-Fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc. Natl. Acad. Sci. U.S.A. 89:4270-4274.
62. Paxinos, G., and C. Watson (1986) The Rat Brain in Stereotaxic Coordinates, 2nd ed. New York: Academic Press.
63. Pickar, D., and A. Breier (1989) Clinical and biochemical effects of neuroleptic treatment: implications for the pathophysiology of schizophrenia. In S.C. Schulz and C.A. Tamminga (eds): Schizophrenia: Scientific Progress. New York: Oxford University Press, pp. 285-301.
64. Reiner, A., and K.D. Anderson (1990) The patterns of neurotransmitter and neuropeptide co-occurrence among striatal projection neurons: conclusions based on recent findings. Brain Res. Rev. 15:251-265.
65. Robertson, G.S., and H.C. Fibiger (1992) Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience 46:315-328.
66. Robertson, G.S., S.R. Vincent, and H.C. Fibiger (1992) D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience 49:285-296.
67. Sandell, J.H., A.M. Graybiel, and M.F. Chesselet (1986) A new enzyme marker for striatal compartmentalization: NADPH diaphorase activity in the caudate nucleus and putamen of the cat. J. Comp. Neurol. 243:326-334.
68. Saper, C.B. (1996) Any way you slice it: a new Journal policy for the use of unbiased counting methods. J. Comp. Neurol. 364:5.
69. Schulz, S.C., R.R. Conley, E.M. Kahn, and J. Alexander (1989) Nonresponders to neuroleptics: a distinct subtype. In S.C. Schulz and C.A. Tamminga (eds): Schizophrenia: Scientific Progress. New York: Oxford University Press, pp. 341-357.
70. Sebens, J.B., T. Koch, G.J. Ter Horst, and J. Korf (1995) Differential Fos-protein induction in rat forebrain regions after acute and long-term haloperidol and clozapine treatment. Eur. J. Pharmacol. 273:175-182.
71. Seeman, P. (1990) Atypical neuroleptics: role of multiple receptors, endogenous dopamine, and receptor linkage. Acta Psychiatr. Scand. 82(Suppl. 358):14-20.
72. Sheng, M., and M.E. Greenberg (1990) The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron 4:477-485.
73. Stern, R.G., R. Kahn, P.D Harvey, F. Amin, S.H. Apter, and J. Hirschowitz (1993) Early response to haloperidol treatment in chronic schizophrenia. Schizophr. Res. 10:165-171.
74. Stevens, J.R. (1973) An anatomy of schizophrenia? Arch. Gen. Psychiatry 29:177-189.
75. Sunahara, R.K., P. Seeman, H.H.M. Van Tol, and H.B. Niznik (1993) Dopamine receptors and antipsychotic drug response. Br. J. Psychiatry 163(Suppl. 22):31-38.
76. Vincent, S.R., and T. Johansson (1983) Striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities and NADPH-diaphorase activity: a light and electron microscopic study. J. Comp. Neurol. 217:264-270.
77. Vincent, S.R., O. Johansson, T. Hökfelt, L. Skirboll, R.P. Eide, L. Terenius, J. Kimmel, and M. Goldstein (1983) NADPH-diaphorase: a selective histochemical marker for striatal neurons containing both somatostatin and avian pancreatic polypeptide (APP)-like immunoreactivities. J. Comp. Neurol. 217:252-263.
78. Walaas, S.I., and P. Greengard (1984) DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain. J. Neurosci. 4:84-98.
79. White, F.J., and R.Y. Wang (1983) Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 221:1054-1057.
80. Wisden, W., M.L. Errington, S. Williams, S.B. Dunnett, C. Waters, D. Hitchcock, G. Evan, T.V. Bliss, and S.P. Hunt (1990) Differential expression of immediate early genes in the hippocampus and spinal cord. Neuron 4:603-614.
81. Wood, G. (1978) An adverse reaction to metoclopramide therapy. Br. J. Oral Surg. 15:278-280.
82. Young, S.T., L.J. Porrino, and M.J. Iadarola (1991) Cocaine induces striatal c-Fos-immunoreactive proteins via dopaminergic D1 receptors. Proc. Natl. Acad. Sci. U.S.A. 88:1291-1295.
83. Yoshikawa, K., C. Williams, and S.L. Sabol (1984) Rat brain preproenkephalin mRNA. cDNA cloning, primary structure, and distribution in the central nervous system. J. Biol. Chem. 259:14301-14308.